Chlamydia trachomatis variant with nonfusing inclusions: Growth dynamic and host-cell transcriptional response

Journal of Infectious Diseases

Volumn 192, Issue 7, 2005, Pages 1229-1236

  Xia, Minsheng ^a   Suchland, Robert J ^a   Bumgarner, Roger E ^a   Peng, Tao ^a   Rockey, Daniel D ^b   Stamm, Walter E ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA 16S;

ANALYTICAL PARAMETERS; ARTICLE; BACTERIAL GROWTH; CELL INCLUSION; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; COLONY FORMING UNIT; CONTROLLED STUDY; DNA MICROARRAY; GENE INDUCTION; GENE REPRESSION; GENETIC TRANSCRIPTION; GLOBAL EXPRESSION MICROARRAY; GROWTH RATE; HELA CELL; HOST CELL; HUMAN; HUMAN CELL; IMMUNITY; INCLUSION FORMING UNIT; LIPID METABOLISM; MULTIPLICITY OF INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPIC VARIATION; PRIORITY JOURNAL;

CHLAMYDIA TRACHOMATIS; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; INCLUSION BODIES; LIPIDS; MEMBRANE FUSION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 16S; TRANSCRIPTION, GENETIC; VARIATION (GENETICS);

EID: 25444480304     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/444394     Document Type: Article

References (23)

1. Stamm WE. Chlamydia trachomatis infections: progress and problems. J Infect Dis 1999; 179(Suppl 2):S380-3.
2. Moulder JW. Interaction of chlamydiae and host cells in vitro. Microbiol Rev 1991; 55:143-90.
3. Hackstadt T, Fischer ER, Scidmore MA, Rockey DD, Heinzen RA. Origins and functions of the chlamydial inclusion. Trends Microbiol 1997; 5:288-93.
4. Rockey DD, Viratyosin W, Bannantine JP, Suchland RJ, Stamm WE. Diversity within inc genes of clinical Chlamydia trachomatis variant isolates that occupy non-fusogenic inclusions. Microbiology 2002; 148: 2497-505.
5. Suchland RJ, Rockey DD, Bannantine JP, Stamm WE. Isolates of Chlamydia trachomatis that occupy nonfusogenic inclusions lack IncA, a protein localized to the inclusion membrane. Infect Immun 2000; 68: 360-7.
6. Geisler WM, Suchland RJ, Rockey DD, Stamm WE. Epidemiology and clinical manifestations of unique Chlamydia trachomatis isolates that occupy nonfusogenic inclusions. J Infect Dis 2001; 184:879-84.
7. Stephens RS, Kalman S, Lammel C, et al. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 1998; 282:754-9.
8. Xia M, Bumgarner RE, Lampe MF, Stamm WE. Chlamydia trachomatis infection alters host cell transcription in diverse cellular pathways. J Infect Dis 2003; 187:424-34.
9. Caldwell HD, Kromhout J, Schachter J. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun 1981; 31:1161-76.
10. Mathews SA, Volp KM, Timms P. Development of a quantitative gene expression assay for Chlamydia trachomatis identified temporal expression of σ factors. FEBS Lett 1999; 458:354-8.
11. Gourse RL, Gaal T, Bartlett MS, Appleman JA, Ross W. rRNA transcription and growth rate-dependent regulation of ribosome synthesis in Escherichia coli. Annu Rev Microbiol 1996; 50:645-77.
12. Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000; 25:25-9.
13. Stephens RS. Challenge of Chlamydia research. Infect Agents Dis 1992; 1:279-93.
14. Stephens RS. The cellular paradigm of chlamydial pathogenesis. Trends Microbiol 2003; 11:44-51.
15. Wylie JL, Hatch GM, McClarty G. Host cell phospholipids are trafficked to and then modified by Chlamydia trachomatis. J Bacteriol 1997; 179: 7233-42.
16. Hatch GM, McClarty G. Phospholipid composition of purified Chlamydia trachomatis mimics that of the eucaryotic host cell. Infect Immun 1998; 66:3727-35.
17. Carabeo RA, Mead DJ, Hackstadt T. Golgi-dependent transport of cholesterol to the Chlamydia trachomatis inclusion. Proc Natl Acad Sci USA 2003; 100:6771-6.
18. Kehrl JH, Sinnarajah S. RGS2: a multifunctional regulator of G-protein signaling. Int J Biochem Cell Biol 2002; 34:432-8.
19. Leffers H, Nielsen MS, Andersen AH, et al. Identification of two human Rho GDP dissociation inhibitor proteins whose overexpression leads to disruption of the actin cytoskeleton. Exp Cell Res 1993; 209:165-74.
20. Brunelle BW, Nicholson TL, Stephens RS. Microarray-based genomic surveying of gene polymorphisms in Chlamydia trachomatis. Genome Biol 2004; 5:R42.
21. Carlson JH, Hughes S, Hogan D, et al. Polymorphisms in the Chlamydia trachomatis cytotoxin locus associated with ocular and genital isolates. Infect Immun 2004; 72:7063-72.
22. Stothard DR, Toth GA, Batteiger BE. Polymorphic membrane protein H has evolved in parallel with the three disease-causing groups of Chlamydia trachomatis. Infect Immun 2003; 71:1200-8.
23. Yuan Y, Zhang YX, Watkins NG, Caldwell HD. Nucleotide and deduced amino acid sequences for the four variable domains of the major outer membrane proteins of the 15 Chlamydia trachomatis serovars. Infect Immun 1989; 57:1040-9.